Post-earnings recap
Reported
Thu, Feb 27, 2025
EPS actual
$-0.67
EPS est.
$-0.82
EPS surprise
+18.79%
1-day move
-1.54%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Denali Therapeutics reported a wider-than-expected loss per share, beating the consensus estimate on EPS but not providing revenue figures. The stock reacted negatively, declining by 1.54%, likely due to the lack of revenue information and forward guidance, which investors often look for in earnings reports.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.67 | N/A | +18.79% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.